As per WHO/HIV Resnet recommended protocol using 60 – 70 specimens from HIV positive recently infected population.
Anonymous unlinked testing of those fulfilling inclusion criteria.
Steering Committee Technical Committee WG WG WG WG WG HIVResNet WHO Secretariat Epidemiology Data use Technology transfer Data Management Lab T he World Health Organization has brought together a global group of experts and organizations to develop and implement surveillance and monitoring methods to support the containment of HIV drug resistance (HIVDR) as antiretroviral treatment (ART) is rolled out worldwide. A formal laboratory network with QA/QC and certification will begin this year. Each working group (WG) is co-chaired by 1 developing country expert + 1 industrialized country expert